Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-26-100234
Filing Date
2026-03-10
Accepted
2026-03-10 16:31:54
Documents
19
Effectiveness Date
2026-03-10

Document Format Files

Seq Description Document Type Size
1 S-3ASR d25619ds3asr.htm S-3ASR 466201
2 EX-1.2 d25619dex12.htm EX-1.2 209556
3 EX-4.5 d25619dex45.htm EX-4.5 288418
4 EX-4.6 d25619dex46.htm EX-4.6 292478
5 EX-5.1 d25619dex51.htm EX-5.1 13858
6 EX-5.2 d25619dex52.htm EX-5.2 7786
7 EX-23.1 d25619dex231.htm EX-23.1 2022
8 EX-FILING FEES d25619dexfilingfees.htm   iXBRL EX-FILING FEES 31009
9 GRAPHIC g25619g01a01.jpg GRAPHIC 33402
  Complete submission text file 0001193125-26-100234.txt   1482897

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT d25619dexfilingfees_htm.xml XML 12309
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-294185 | Film No.: 26739808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)